| MeSH term | MeSH ID | Detail |
|---|---|---|
| Adrenoleukodystrophy | D000326 | 29 associated lipids |
| Refsum Disease | D012035 | 19 associated lipids |
| Leukemia | D007938 | 74 associated lipids |
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Lipid Metabolism, Inborn Errors | D008052 | 26 associated lipids |
| Hyperlipoproteinemia Type II | D006938 | 22 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Hypergammaglobulinemia | D006942 | 9 associated lipids |
| Niemann-Pick Diseases | D009542 | 25 associated lipids |
| Glioblastoma | D005909 | 27 associated lipids |
Mevalonic acid
Mevalonic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 10134 references associated with Mevalonic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Mevalonic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Mevalonic acid
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with Mevalonic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Beckman JA and Creager MA | The nonlipid effects of statins on endothelial function. | 2006 | Trends Cardiovasc. Med. | pmid:16781949 |
| Fessler MB | The Intracellular Cholesterol Landscape: Dynamic Integrator of the Immune Response. | 2016 | Trends Immunol. | pmid:27692616 |
| Poirier J | Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. | 2003 | Trends Mol Med | pmid:12657430 |
| Eisenreich W et al. | Deoxyxylulose phosphate pathway to terpenoids. | 2001 | Trends Plant Sci. | pmid:11173292 |
| Montoya CJ et al. | Antiretroviral effect of lovastatin on HIV-1-infected individuals without highly active antiretroviral therapy (The LIVE study): a phase-II randomized clinical trial. | 2009 | Trials | pmid:19538732 |
| Greife A et al. | Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation. | 2015 | Tumour Biol. | pmid:25566959 |
| Neville-Webbe HL et al. | Mechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitro. | 2006 | Tumour Biol. | pmid:16582586 |
| Grigore L et al. | Combination therapy in cholesterol reduction: focus on ezetimibe and statins. | 2008 | Vasc Health Risk Manag | pmid:18561502 |
| Corsini A et al. | Are pleiotropic effects of statins real? | 2007 | Vasc Health Risk Manag | pmid:18078012 |
| Rothwell C et al. | Cholesterol biosynthesis modulation regulates dengue viral replication. | 2009 | Virology | pmid:19419745 |
| Lin YL et al. | Cholesterol requirement of hepatitis B surface antigen (HBsAg) secretion. | 2003 | Virology | pmid:14517078 |
| Lyles DS et al. | An alteration in the kinetic properties of a cholesterogenic enzyme in fowlpox virus infection. | 1975 | Virology | pmid:237362 |
| Sidorkiewicz M et al. | Mevalonate pathway modulation is associated with hepatitis C virus RNA presence in peripheral blood mononuclear cells. | 2009 | Virus Res. | pmid:19540284 |
| Targett-Adams P et al. | Lipid metabolism and HCV infection. | 2010 | Viruses | pmid:21994676 |
| Delang L et al. | Antiviral therapy for hepatitis C virus: beyond the standard of care. | 2010 | Viruses | pmid:21994657 |
| Rad SA et al. | Type 2 IDI performs better than type 1 for improving lycopene production in metabolically engineered E. coli strains. | 2012 | World J. Microbiol. Biotechnol. | pmid:22806807 |
| Akisato Y et al. | [Effect of pitavastatin on macrophage cholesterol metabolism]. | 2008 | Yakugaku Zasshi | pmid:18311054 |
| Iguchi K | [Effect of bisphosphonates on anticancer activity in prostate cancer cells]. | 2012 | Yakugaku Zasshi | pmid:23023419 |
| Tokoro T et al. | The novel HMG-CoA reductase inhibitor, Pitavastatin, induces a protective action in vascular endothelial cells through the production of nitric oxide (NO). | 2004 | Yakugaku Zasshi | pmid:15049129 |